Use of Anakinra in Patients with Cryopyrin-Associated Periodic Syndromes and Other Autoinflammatory Diseases
The article describes the main autoinflammatory syndromes as well as the key role of interleukin (IL) 1 in the pathogenesis of these diseases. It also presents the data on the experience of anakinra using (soluble IL-1 receptor antagonist) as well as the results of randomized clinical trials and des...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
"Paediatrician" Publishers LLC,
2016-12-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | The article describes the main autoinflammatory syndromes as well as the key role of interleukin (IL) 1 in the pathogenesis of these diseases. It also presents the data on the experience of anakinra using (soluble IL-1 receptor antagonist) as well as the results of randomized clinical trials and descriptions of anakinra use case series in autoinflammatory and a number of other non-rheumatic diseases. The data on the efficacy and safety of a soluble IL-1 receptor antagonist is given. |
|---|---|
| Item Description: | 1682-5527 1682-5535 10.15690/vsp.v15i6.1654 |